Neurobiology of Aging
Volume 28, Issue 4 , Pages 524-532 , April 2007

Chlamydia pneumoniae infection of brain cells: An in vitro study

  • Ellen Boelen

      Affiliations

    • Department of Medical Microbiology, CARIM (Cardiovascular Research Institute Maastricht), Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • Department of Cellular Neuroscience, EURON (European Graduate School of Neurosciences), Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Harry W.M. Steinbusch

      Affiliations

    • Department of Cellular Neuroscience, EURON (European Graduate School of Neurosciences), Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • André J.A.M. van der Ven

      Affiliations

    • Department of General Internal Medicine, University Medical Centre St. Radbaud, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Gert Grauls

      Affiliations

    • Department of Medical Microbiology, CARIM (Cardiovascular Research Institute Maastricht), Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Cathrien A. Bruggeman

      Affiliations

    • Department of Medical Microbiology, CARIM (Cardiovascular Research Institute Maastricht), Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Frank R.M. Stassen

      Affiliations

    • Department of Medical Microbiology, CARIM (Cardiovascular Research Institute Maastricht), Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 43 387 4663; fax: +31 43 387 6643.

Received 18 October 2005 ,Revised 14 February 2006 ,Accepted 16 February 2006.

References 

  1. Balin BJ, Appelt DM. Role of infection in Alzheimer's disease. J Am Osteopath Assoc. 2001;101(12 Suppl Pt 1):S1–S6
  2. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (Berl). 1998;187(1):23–42
  3. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol. 1990;27(2–3):229–237
  4. Bruunsgaard H, Ostergaard L, Andersen-Ranberg K, Jeune B, Pedersen BK. Proinflammatory cytokines, antibodies to Chlamydia pneumoniae and age-associated diseases in Danish centenarians: is there a link?. Scand J Infect Dis. 2002;34(7):493–499
  5. Dobson CB, Itzhaki RF. Herpes simplex virus type 1 and Alzheimer's disease. Neurobiol Aging. 1999;20(4):457–465
  6. Ezzahiri R, Stassen FR, Kurvers HA, van Pul MM, Kitslaar PJ, Bruggeman CA. Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice. Eur J Vasc Endovasc Surg. 2003;26(1):88–95
  7. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun. 1996;64(5):1614–1620
  8. Gieffers J, Fullgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA, et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation. 2001;103(3):351–356
  9. Gieffers J, Reusche E, Solbach W, Maass M. Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients. J Clin Microbiol. 2000;38(2):881–882
  10. Grayston JT, Aldous MB, Easton A, Wang SP, Kuo CC, Campbell LA, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis. 1993;168(5):1231–1235
  11. Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990;161(4):618–625
  12. Guglielminotti J, Lellouche N, Maury E, Alzieu M, Guidet B, Offenstadt G. Severe meningoencephalitis: an unusual manifestation of Chlamydia pneumoniae infection. Clin Infect Dis. 2000;30(1):209–210
  13. Hanson LK, Slater JS, Karabekian Z, Virgin HWt, Biron CA, Ruzek MC, et al. Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J Virol. 1999;73(7):5970–5980
  14. Haranaga S, Yamaguchi H, Ikejima H, Friedman H, Yamamoto Y. Chlamydia pneumoniae infection of alveolar macrophages: a model. J Infect Dis. 2003;187(7):1107–1115
  15. Hemling N, Roytta M, Rinne J, Pollanen P, Broberg E, Tapio V, et al. Herpesviruses in brains in Alzheimer's and Parkinson's diseases. Ann Neurol. 2003;54(2):267–271
  16. Kaptein SJ, van Cleef KW, Gruijthuijsen YK, Beuken EV, van Buggenhout L, Beisser PS, et al. The r131 gene of rat cytomegalovirus encodes a proinflammatory CC chemokine homolog which is essential for the production of infectious virus in the salivary glands. Virus Genes. 2004;29(1):43–61
  17. Kolson DL, Gonzalez-Scarano F. HIV and HIV dementia. J Clin Invest. 2000;106(1):11–13
  18. Kuo CC, Grayston JT. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990;162(3):755–758
  19. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc Natl Acad Sci USA. 1995;92(15):6911–6914
  20. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev. 1995;8(4):451–461
  21. Levitt D, Danen R, Levitt P. Selective infection of astrocytes by Chlamydia trachomatis in primary mixed neuron-glial cell cultures. Infect Immun. 1986;54(3):913–916
  22. Lin WR, Wozniak MA, Wilcock GK, Itzhaki RF. Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol Dis. 2002;9(1):82–87
  23. Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging. 2004;25(4):419–429
  24. Mazzini G, Ferrari C, Erba E. Dual excitation multi-fluorescence flow cytometry for detailed analyses of viability and apoptotic cell transition. Eur J Histochem. 2003;47(4):289–298
  25. Molestina RE, Klein JB, Miller RD, Pierce WH, Ramirez JA, Summersgill JT. Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun. 2002;70(6):2976–2981
  26. Nochlin D, Shaw CM, Campbell LA, Kuo CC. Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease. Neurology. 1999;53(8):1888
  27. Perry G, Nunomura A, Lucassen P, Lassmann H, Smith MA. Apoptosis and Alzheimer's disease. Science. 1998;282(5392):1268–1269
  28. Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomura A, Siedlak SL, et al. Abortive apoptosis in Alzheimer's disease. Acta Neuropathol (Berl). 2001;101(4):305–310
  29. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol. 1998;19(5):721–727
  30. Ring RH, Lyons JM. Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain. J Clin Microbiol. 2000;38(7):2591–2594
  31. Roblin PM, Dumornay W, Hammerschlag MR. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol. 1992;30(8):1968–1971
  32. Squire LR, Bloom FE, McConnell SK, Roberts JL, Spitzer NC, Zigmond MJ. Cellular and molecular neuroscience. In:  Squire LR,  Bloom FE,  McConnell SK,  Roberts JL,  Spitzer NC,  Zigmond MJ editor. Fundamental Neuroscience. vol. 2:California: Academic Press/Elsevier Science; 2003;p. 49–339
  33. Sriram S, Stratton CW, Yao S, Tharp A, Ding L, Bannan JD, et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol. 1999;46(1):6–14
  34. Stratton CW, Sriram S. Association of Chlamydia pneumoniae with central nervous system disease. Microbes Infect. 2003;5(13):1249–1253
  35. Streit WJ. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia. 2002;40(2):133–139
  36. Swanborg RH, Whittum-Hudson JA, Hudson AP. Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?. J Neuroimmunol. 2003;136(1/2):1–8
  37. Taylor GS, Vipond IB, Paul ID, Matthews S, Wilcock GK, Caul EO. Failure to correlate C. pneumoniae with late onset Alzheimer's disease. Neurology. 2002;59(1):142–143
  38. Tondella ML, Talkington DF, Holloway BP, Dowell SF, Cowley K, Soriano-Gabarro M, et al. Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae. J Clin Microbiol. 2002;40(2):575–583
  39. Weinberger M. Respiratory infections and asthma: current treatment strategies. Drug Discov Today. 2004;9(19):831–837
  40. Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke. 1996;27(12):2207–2210
  41. Wolf K, Fischer E, Hackstadt T. Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun. 2000;68(4):2379–2385
  42. Yucesan C, Sriram S. Chlamydia pneumoniae infection of the central nervous system. Curr Opin Neurol. 2001;14(3):355–359

PII: S0197-4580(06)00078-9

doi: 10.1016/j.neurobiolaging.2006.02.014

Neurobiology of Aging
Volume 28, Issue 4 , Pages 524-532 , April 2007

Article Tools

* Image Usage & Resolution